|
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective.
Eur Heart J. 2010 Mar;
Spencer FA, Montalescot G, Fox KA, Goodman SG, Granger CB, Goldberg RJ, Oliveira GB, Anderson FA, Eagle KA, Fitzgerald G, Gore JM; for the Global Registry of Acute Coronary Events (GRACE) Investigators. |
|
Preventing Serious Sequelae After an Acute Coronary Syndrome: The Consequences of Thrombosis Versus Bleeding With Antiplatelet Therapy
J Cardiovasc Pharmacol. 2010 Mar;
Islam AM, Patel PM. |
|
Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.
Trends Mol Med. 2008 Sep;
Tousoulis D, Briasoulis A, Papageorgiou N, Antoniades C, Stefanadis C. |
|
Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index.
J Intern Med. 2008 Sep;
Agren A, Wiman B, Schulman S. |
|
Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variant.
Thromb Res. 2008 Sep;
Fahim AT, Wang H, Feng J, Ginsburg D.. |
|
Abstracts of the XIXth International Congress on Fibrinolysis and Proteolysis, 6-10 July 2008, Vienna, Austria.
J Thromb Haemost. 2008 Ago; 6 Suppl (1):1-53.
|
|
Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
Blood Coagul Fibrinolysis. 2008 Jul; 19(5):405-409.
Sidelmann JJ, Bladbjerg EM, Gram J, Münster AM, Jespersen J. |
|
Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis.
Circulation. 2008 Jul; 118(3):219-222.
White HD |
|
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential.
J Thromb Haemost. 2008 Jun; Epub ahead of print
Colucci M, Cattaneo M, Martinelli I, Semeraro F, Binetti BM, Semeraro N. |
|
Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
Am Heart J. 2008 Jun; 155(6):1039-1046. Epub 2008 Mar 7
Brouwer MA, Kievit PC, Dieker HJ, Veen G, Karreman AJ, Verheugt FW. |
|
Relationship of Admission QRS Duration and Changes in QRS Duration With Myocardial Reperfusion in Patients With Acute ST Segment Elevation Myocardial Infarction (STEMI) Treated With Fibrinolytic Therapy.
Circ J. 2008 Jun; 72(6):873-879.
Kacmaz F, Maden O, Aksuyek S, Ureyen C, Alyan O, Erbay AR, Selcuk H, Ulusoy V, Balbay Y, Ilkay E. |
|
Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin.
Thromb Res. 2008 May; 122(2):271-281.
Brogren H, Sihlbom C, Wallmark K, Lönn M, Deinum J, Karlsson L, Jern S. |
|
Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: A gender-stratified, cohort analysis.
Thromb Res. 2008 May;
Shen J, Ran ZH, Zhang Y, Cai Q, Yin HM, Zhou XT, Xiao SD. |
|
Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles.
Shock. 2008 Abr; 29(4):504-511.
Sander TL, Ou JS, Densmore JC, Kaul S, Matus I, Twigger S, Halligan B, Greene AS, Pritchard KA Jr, Oldham KT. |
|
Fibrinolysis: the key to new pathogenetic mechanisms.
Curr Med Chem. 2008 Ene; 15(9):923-929.
Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A. |
|
Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease.
Arterioscler Thromb Vasc Biol . 2007 Jul; 27(7):1651-6. Epub 2007 Abr 26
Simon D. Robinson, Christopher A. Ludlam, Nicholas A. Boon, and David E. Newby |
|
Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
Br J Haematol. 2007 Jul; 138(1):117-24.
Veronica H. Flood, Chandrasekaran Nagaswami, Irina N. Chernysh, Hamid A. Al-Mondhiry, John W. Weisel and David H. Farrell |
|
Blood coagulation activation and fibrinolysis during a downhill marathon run.
Blood Coagul Fibrinolysis. 2007 Jul; 18(5):435-40.
Günther Sumann; Dietmar Fries; Andrea Griesmacher; Gerda Falkensammer; Anton Klingler; Arnold Koller; Werner Streif; Sven Greie; Beatrix Schobersberger; Wolfgang Schobersberger. |
|
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients.
Journal of Thrombosis and Haemostasis . 2007 Jul; 5(7):1509-15.
A. W. J. H. DIELIS, M. SMID, H. M. H. SPRONK, A. J. H. M. HOUBEN, K. HAMULYÁK, A. A. KROON, H. TEN CATE and P. W. DE LEEUW |
|
Determination of the global fibrinolytic state.
Blood Coagul Fibrinolysis. 2007 Jul; 18(5):479-87. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed Abr
Thomas W Stief; Sabrina Fröhlich; Harald Renz. |
